Clinical TrialsSearch results
Number of results: 209
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Other
- A multi-center comparative study of three coma scales: Japan Coma Scale, Glasgow Coma Scale and Emergency Coma Scale : E-COMET STEP I
- consciousness disturbance
- Japan ECS Society
- 2007-04-05
Other
- Assessment study on validity of the Intervention Therapies for coronary artery disease in Japan
- Coronary artery disease
- National Hospital Organization
- 2007-09-01
Recruiting
- [M23-784] A Study to Assess Adverse Events and Change in Disease Activity of Risankizumab Subcutaneous Induction Treatment for Moderately to Severely Active Crohn's Disease.
- Crohn's Disease
- Otani Tetsuya
- 2024-03-11
Recruiting
- Transcatheter arterial micro-embolization for chronic post surgical pain after total knee arthroplasty
- Cronic post-surgical pain after total knee arthroplasty
- Sugimura Natsuki
- 2022-07-06
Other
- A multicentre study on clinical usefulness of urinary trypsinogen-2 for early diagnosis of acute pancreatitis.
- Definite or possible acute pancreatitis.
- Division of Gastroenterology, Tohoku University Graduate School of Medicine
- 2009-01-07
Recruiting
- A study to evaluate the efficacy and safety of subcutaneous amlitelimab in participants aged 18 years and older with moderate-to-severe atopic dermatitis on background topical corticosteroids
- Dermatitis atopic
- Tanaka Tomoyuki
- 2024-01-13
Recruiting
- A study to evaluate the efficacy and safety of subcutaneous amlitelimab monotherapy compared with placebo in participants aged 18 years and older with moderate-to-severe atopic dermatitis
- Dermatitis atopic
- Tanaka Tomoyuki
- 2024-01-13
Recruiting
- A study to evaluate the efficacy and safety of subcutaneous amlitelimab on background topical corticosteroids therapy in participants aged 12 years and older with moderate-to-severe AD who have had an inadequate response to prior biologic therapy or an oral JAK inhibitor
- Dermatitis atopic
- Tanaka Tomoyuki
- 2024-05-08
Recruiting
- A study to evaluate the treatment response and safety of two dose regimens of subcutaneous amlitelimab monotherapy compared with treatment withdrawal in participants aged 12 years and older with moderate-to-severe atopic dermatitis
- Dermatitis atopic
- Tanaka Tomoyuki
- 2024-06-28
Recruiting
- Open label, long-term study evaluating safety and efficacy of subcutaneous amlitelimab in adult participants with moderate to severe atopic dermatitis
- Dermatitis atopic
- Tanaka Tomoyuki
- 2023-03-20